- Home
- CLLS vs ATOM Comparison
CLLS vs ATOM Comparison
Compare CLLS & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- ATOM
- Stock Information
- Founded
- CLLS 1999
- ATOM 2001
- Country
- CLLS France
- ATOM United States
- Employees
- CLLS N/A
- ATOM N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- ATOM Semiconductors
- Sector
- CLLS Health Care
- ATOM Technology
- Exchange
- CLLS Nasdaq
- ATOM Nasdaq
- Market Cap
- CLLS 143.4M
- ATOM 155.4M
- IPO Year
- CLLS 2007
- ATOM 2016
- Fundamental
- Price
- CLLS $2.95
- ATOM $4.66
- Analyst Decision
- CLLS Buy
- ATOM Strong Buy
- Analyst Count
- CLLS 1
- ATOM 1
- Target Price
- CLLS $4.00
- ATOM $7.00
- AVG Volume (30 Days)
- CLLS 310.2K
- ATOM 405.6K
- Earning Date
- CLLS 08-04-2025
- ATOM 08-05-2025
- Dividend Yield
- CLLS N/A
- ATOM N/A
- EPS Growth
- CLLS N/A
- ATOM N/A
- EPS
- CLLS N/A
- ATOM N/A
- Revenue
- CLLS $54,747,000.00
- ATOM $121,000.00
- Revenue This Year
- CLLS N/A
- ATOM $202.22
- Revenue Next Year
- CLLS $4.90
- ATOM $1,225.00
- P/E Ratio
- CLLS N/A
- ATOM N/A
- Revenue Growth
- CLLS 351.26
- ATOM N/A
- 52 Week Low
- CLLS $1.10
- ATOM $2.31
- 52 Week High
- CLLS $3.10
- ATOM $17.55
- Technical
- Relative Strength Index (RSI)
- CLLS 69.22
- ATOM 38.07
- Support Level
- CLLS $2.43
- ATOM $4.92
- Resistance Level
- CLLS $3.10
- ATOM $5.40
- Average True Range (ATR)
- CLLS 0.27
- ATOM 0.29
- MACD
- CLLS 0.08
- ATOM -0.00
- Stochastic Oscillator
- CLLS 88.72
- ATOM 20.00
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.